We are streamlining death.
The federal government on Thursday permanently lifted a major restriction on access to abortion pills. It will allow patients to receive the medication by mail instead of requiring them to obtain the pills in person from specially certified health providers.
The decision, by the Food and Drug Administration, comes as the Supreme Court is considering whether to roll back abortion rights or even overturn its landmark 1973 decision in Roe v. Wade that made abortion legal nationwide.
The F.D.A.’s action means that medication abortion, an increasingly common method authorized in the United States for pregnancies up to 10 weeks’ gestation, will become more available to women who find it difficult to travel to an abortion provider or prefer to terminate a pregnancy in their homes. It allows patients to have a telemedicine appointment with a provider who can prescribe abortion pills and send them to the patient by mail.
Earlier this year, for the duration of the pandemic, the F.D.A. temporarily lifted the in-person requirement on mifepristone, the first of two drugs used to end a pregnancy. The decision to make this change permanent is likely to deepen the already polarizing divisions between conservative and liberal states on abortion. In 19 states, mostly in the South and the Midwest, telemedicine visits for medication abortion are banned, and these and other conservative states can be expected to pass other laws to further curtail access to abortion pills.
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- Hey, Whatever Happened to Richard Gere? Oh, He Criticized China.
- Jordan Peterson resigns as tenured University of Toronto professor, torpedoes academia as ‘stunningly corrupt enterprise’
- Video Shows U.S. Capitol Police Gave Protesters OK to Enter
- Aussie Police confirm use of controversial LRAD Weapon against Canberra protestors
- Campus Crusade for Christ Goes All In On Critical Race Theory
- Liars Game — CDC withheld massive amounts of COVID data to ‘prevent vaccine hesitancy’